Sorafenib Terminated Phase 2 Trials for Fallopian Tube Cancer / Primary Peritoneal Cavity Cancer / Ovarian Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00522301Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission